Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery

Critical Care Medicine

Volumn 37, Issue 4, 2009, Pages 1293-1298

  Rioux, Jean Philippe ^a   Lessard, Myriam ^a   De Bortoli, Bruno ^a   Roy, Patrick ^a   Albert, Martin ^a   Verdant, Colin ^a   Madore, François ^a   Troyanov, Stéphan ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Acute kidney injury; Cardiac surgery; Colloid therapy; Pentastarch; Propensity analysis

Indexed keywords

ADRENALIN; CREATININE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; HETASTARCH; HYPERTENSIVE FACTOR; NORADRENALIN;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EXTRACORPOREAL CIRCULATION; FEMALE; GROUPS BY AGE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PLASMA TRANSFUSION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR;

ACUTE KIDNEY INJURY; AGED; CARDIAC SURGICAL PROCEDURES; FEMALE; HETASTARCH; HUMANS; MALE; PLASMA SUBSTITUTES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 67650507078     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819cc1a0     Document Type: Article

References (47)

1. Rosner MH, Okusa MD: Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 2006; 1:19-32
2. Conlon PJ, Stafford-Smith M, White WD, et al: Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999; 14: 1158-1162
3. Del Duca D, Iqbal S, Rahme E, et al: Renal failure after cardiac surgery: Timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 2007; 84: 1264-1271
4. Brown JR, Cochran RP, Leavitt BJ, et al: Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation 2007; 116:I139-I143
5. Chertow GM, Lazarus JM, Christiansen CL, et al: Preoperative renal risk stratification. Circulation 1997; 95:878-884
6. Thakar CV, Arrigain S, Worley S, et al: A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16:162-168
7. Wijeysundera DN, Karkouti K, Dupuis JY, et al: Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007; 297: 1801-1809
8. Fortescue EB, Bates DW, Chertow GM: Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms. Kidney Int 2000; 57:2594-2602
9. Mehta RH, Grab JD, O'Brien SM, et al: Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006; 114:2208-2216; quiz 2208
10. Rex S, Scholz M, Weyland A, et al: Intra- and extravascular volume status in patients undergoing mitral valve replacement: Crystalloid vs. colloid priming of cardiopulmonary bypass. Eur J Anaesthesiol 2006; 23:1-9
11. Russell JA, Navickis RJ, Wilkes MM: Albumin versus crystalloid for pump priming in cardiac surgery: Meta-analysis of controlled trials. J Cardiothorac Vasc Anesth 2004; 18: 429-437
12. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch re-suscitation in severe sepsis. N Engl J Med 2008; 358:125-139
13. Schortgen F, Deye N, Brochard L: Preferred plasma volume expanders for critically ill patients: Results of an international survey. Intensive Care Med 2004; 30:2222-2229
14. Miletin MS, Stewart TE, Norton PG: Influences on physicians' choices of intravenous colloids. Intensive Care Med 2002; 28: 917-924
15. Davidson IJ: Renal impact of fluid management with colloids: A comparative review. Eur J Anaesthesiol 2006; 23:721-738
16. Winkelmayer WC, Glynn RJ, Levin R, et al: Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003; 64:1046-1049
17. Cockcroft DW, Gault MH: Prediction of cre-atinine clearance from serum creatinine. Nephron 1976; 16:31-41
18. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
19. Bellomo R, Ronco C, Kellum JA, et al: Acute renal failure - Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8:R204-R212
20. Kleinbaum DG, Kupper LL, Muller KE: Applied Regression Analysis and Other Multivariable Methods. Second Edition. Belmont, CA, Duxbury Press, 1988
21. Weitzen S, Lapane KL, Toledano AY, et al: Principles for modeling propensity scores in medical research: a systematic literature review. Pharmacoepidemiol Drug Saf 2004; 13: 841-853
22. Bunn F, Trivedi D, Ashraf S: Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2008; CD001319
23. Gallandat Huet RC, Siemons AW, Baus D, et al: A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000; 47:1207-1215
24. James MF, Latoo MY, Mythen MG, et al: Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers. Anaesthesia 2004; 59:738-742
25. Jungheinrich C, Neff TA: Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44:681-699
26. Waitzinger J, Bepperling F, Pabst G, et al: Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Investig 1998; 16:151-160
27. Waitzinger J, Bepperling F, Pabst G, et al: Hydroxyethyl starch (HES) [130/0.4], a new HES specification: Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 2003; 4:149-157
28. Lazrove S, Waxman K, Shippy C, et al: Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients. Crit Care Med 1980; 8:302-306
29. Boldt J, Muller M, Heesen M, et al: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 1996; 24:385-391
30. Schortgen F, Lacherade JC, Bruneel F, et al: Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet 2001; 357:911-916
31. Wiedermann CJ: Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 2008; 8:1
32. Cittanova ML, Leblanc I, Legendre C, et al: Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-1622
33. Boldt J, Knothe C, Schindler E, et al: Volume replacement with hydroxyethyl starch solution in children. Br J Anaesth 1993; 70: 661-665
34. Boldt J, Brenner T, Lehmann A, et al: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin. Intensive Care Med 2003; 29:763-769
35. Boldt J, Brosch C, Ducke M, et al: Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin. Crit Care Med 2007; 35: 2740-2746
36. Mahmood A, Gosling P, Vohra RK: Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94:427-433
37. Blasco V, Leone M, Antonini F, et al: Comparison of the novel hydroxyethylstarch 130/ 0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 2008; 100:504-508
38. Boldt J: Pro: use of colloids in cardiac surgery. J Cardiothorac Vasc Anesth 2007; 21: 453-456
39. De Labarthe A, Jacobs F, Blot F, et al: Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 2001; 111:417-418
40. Hamrock DJ: Adverse events associated with intravenous immunoglobulin therapy. Int Immunopharmacol 2006; 6:535-542
41. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470
42. Nilsson J, Algotsson L, Hoglund P, et al: Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 2006; 27:867-874
43. Nashef SA, Roques F, Michel P, et al: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13
44. Bernstein AD, Parsonnet V: Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg 2000; 69: 823-828
45. Bagshaw SM, George C, Dinu I, et al: A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1203-1210
46. Uchino S, Bellomo R, Goldsmith D, et al: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34:1913-1917
47. Dickenmann M, Oettl T, Mihatsch MJ: Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008; 51:491-503